Abstract
The scope of immune monitoring is to define the existence, magnitude, and quality of immune mechanisms operational in a host. In clinical trials and praxis, the assessment of humoral immunity is commonly confined to measurements of serum antibody reactivity without accounting for the memory B cell potential. Relying on fundamentally different mechanisms, however, passive immunity conveyed by pre-existing antibodies needs to be distinguished from active B cell memory. Here, we tested whether, in healthy human individuals, the antibody titers to SARS-CoV-2, seasonal influenza, or Epstein–Barr virus antigens correlated with the frequency of recirculating memory B cells reactive with the respective antigens. Weak correlations were found. The data suggest that the assessment of humoral immunity by measurement of antibody levels does not reflect on memory B cell frequencies and thus an individual’s potential to engage in an anamnestic antibody response against the same or an antigenically related virus. Direct monitoring of the antigen-reactive memory B cell compartment is both required and feasible towards that goal.
Funder
R&D budget of Cellular Technology Limited
Reference96 articles.
1. B cell memory: Building two walls of protection against pathogens;Nat. Rev. Immunol.,2019
2. Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle;Front. Immunol.,2019
3. Metabolic properties of IgG subclasses in man;J. Clin. Investig.,1970
4. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin;J. Lab. Clin. Med.,1988
5. Nunez, I., Carlock, M.A., Allen, J.D., Owino, S.O., Moehling, K.K., Nowalk, P., Susick, M., Diagle, K., Sweeney, K., and Mundle, S. (2017). Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS ONE, 12.